[1]
[2] 梁朝霞,陈丹青.产后出血的高危因素和流行病学新特点[J].实用妇产科杂志,2012,28(11):897.
[3] ZELOP CM.Postpartum hemorrhage:becoming more evidence-based[J].Obstet Gynecol,2011,117(1):3.
[4] 刘晶,金子玉,孟涛.剖宫产术中缩宫素不同用法的临床疗效比较[J].实用妇产科杂志,2014,30(4):310.
[5] KHAN M,BALKI M,AHMED I,et al.Carbetocin at elective Cesarean delivery:a sequential allocation trial to determine the minimum effective dose[J].Can J Anaesth,2014,61(3):242.
[6] LEE AI,WONG CA,HEALY L,et al.Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes[J].Int J Obstet Anesth,2014,23(1):18.
[7] 徐天星,李雅兰,周锦财,等.胎盘体视学分析不同升压药防治剖宫产低血压的效果[J].南方医科大学学报,2014,34(8):1154.
[8] 何亚军,谭宪湖,刘敬臣.不同速率去氧肾上腺素预防腰硬联合麻醉下行剖宫产术产妇低血压的效果观察[J].山东医药,2013,53(17):68.
[9] 颜建英,徐霞,徐榕莉,等.产后出血不同时段出血量的危险因素分析[J].实用妇产科杂志,2012,28(3):201.
[10]
[11] PISANI I,TIRALONGO GM,GAGLIARDI G,et al.The maternal cardiovascular effect of carbetocin compared to oxytocin in women undergoing caesarean section[J].Pregnancy Hypertens,2012,2(2):139.
[12] 王新彦,李洪霞,冀涛.剖宫产产后出血的相关因素病例对照研究[J].中国妇幼保健,2013,28(6):1052.
[13] YAMAGUCHI ET,CARDOSO MM,TORRES ML,et al.Payen D:Serum oxytocin concentrations in elective caesarean delivery:a randomized comparison of three infusion regimens[J].Int J Obstet Anesth,2011,20(3):224.
[14] 黄秀,何敏,刘映江,等.缩宫素对超声消融治疗子宫肌瘤效果的影响[J].中华妇产科杂志,2011,46(6):412.
[15] BHATTACHARYA S,GHOSH S,RAY D,et al.Oxytocin administration during cesarean delivery:Randomized controlled trial to compare intravenous bolus with intravenous infusion regimen[J].J Anaesthesiol Clin Pharmacol,2013,29(1):32.